南京新百：11月28日召开董事会会议

Company Overview - Nanjing Xinbai (SH 600682) announced the convening of its 23rd meeting of the 10th Board of Directors on November 28, 2025, via communication voting, which reviewed the proposal to amend the "Working Rules of the Board Audit Committee" [1] Financial Performance - For the first half of 2025, Nanjing Xinbai's revenue composition was as follows: 33.68% from health and elderly care, 23.16% from pharmaceutical manufacturing, 15.25% from professional technical services, 14.61% from medical services, and 5.89% from commodity circulation [1] Market Capitalization - As of the report date, Nanjing Xinbai's market capitalization stood at 10.5 billion yuan [1]